Clinical efficacy of 2-week and 3-week albumin-bound paclitaxel therapy for advanced pancreatic cancer

The clinical efficacy of nab-PTX in the 2-week and dose intensive 3 week did not show significant difference, but the 2-week treatment group had better tolerance and safety.

Authors

Institutions

Publication Details

Journal
Future Science OA
Published
2026-01-26
DOI
https://doi.org/10.1080/20565623.2026.2617117
Primary Topic
Pancreatic and Hepatic Oncology Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clinical efficacy of 2-week and 3-week albumin-bound paclitaxel therapy for advanced pancreatic cancer

Zhiyong Li, Jiana Jiang, Feng Shen, Zhimin Su
Future Science OA
Pancreatic and Hepatic Oncology Research
article

Clinical efficacy of 2-week and 3-week albumin-bound paclitaxel therapy for advanced pancreatic cancer

Zhiyong Li, Jiana Jiang, Feng Shen, Zhimin Su
article en

Abstract

The clinical efficacy of nab-PTX in the 2-week and dose intensive 3 week did not show significant difference, but the 2-week treatment group had better tolerance and safety.

Future Science OAVol. 12(1)
Fudan University (CN), Precision for Medicine (United States) (US), Zhongshan Hospital of Xiamen University (CN), Zhongshan Hospital (CN), Center for Cancer Research (US)
Good health and well-being
Openalex Percentile: Top 77%
Pancreatic and Hepatic Oncology Research
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.